Insights on functionalized carbon nanotubes for cancer theranostics

L Tang, Q Xiao, Y Mei, S He, Z Zhang, R Wang… - Journal of …, 2021 - Springer
Despite the exciting breakthroughs in medical technology, cancer still accounts for one of
the principle triggers of death and conventional therapeutic modalities often fail to attain an …

Classic and new markers in diagnostics and classification of breast cancer

R Beňačka, D Szabóová, Z Guľašová, Z Hertelyová… - Cancers, 2022 - mdpi.com
Simple Summary With ever-increasing incidence, breast cancer is considered a most
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …

Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update

VGSS Jyothi, R Bulusu, BVK Rao, M Pranothi… - International Journal of …, 2022 - Elsevier
Liposomes have several advantages, such as the ability to be employed as a carrier/vehicle
for a variety of drug molecules and at the same time they are safe and biodegradable. In the …

Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer

R Farghadani, R Naidu - International Journal of Molecular Sciences, 2022 - mdpi.com
Female breast cancer is the world's most prevalent cancer in 2020. Chemotherapy still
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …

Targeting drug chemo-resistance in cancer using natural products

WH Talib, AR Alsayed, M Barakat, MI Abu-Taha… - Biomedicines, 2021 - mdpi.com
Cancer is one of the leading causes of death globally. The development of drug resistance
is the main contributor to cancer-related mortality. Cancer cells exploit multiple mechanisms …

Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives

Z Jing, Q Du, X Zhang, Y Zhang - Chemical Engineering Journal, 2022 - Elsevier
The field of nanomedicines and nanomaterials has been rapidly developing with several
considerable breakthroughs in the treatment of cancer. However, some challenges may …

TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy

DD Singh, DK Yadav - Biomedicines, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with
a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target …

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

F Yang, Q He, X Dai, X Zhang, D Song - Frontiers in pharmacology, 2023 - frontiersin.org
Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in the
world. BC is the heterogeneous tumor with different subtypes including luminal A-like …

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics

Y Cen, L Chen, Z Liu, Q Lin, X Fang, H Yao… - Cell death …, 2023 - nature.com
Therapy resistance remains a huge challenge for current breast cancer treatments.
Exploring molecular mechanisms of therapy resistance might provide therapeutic targets for …

Tumor microenvironment diversity and plasticity in cancer multidrug resistance

Z Li, P Yin - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
Multidrug resistance (MDR) poses a significant obstacle to effective cancer treatment, and
the tumor microenvironment (TME) is crucial for MDR development and reversal. The TME …